Careers  |  Sign In  |  Register

Latest in Hematology-Oncology

Reuters Health • The Doctor's Channel Daily Newscast

No survival benefit to adjuvant chemo in older adults with stage II colon cancer

NEW YORK (Reuters Health) – A new study suggests that, in a real-world setting, adjuvant chemotherapy in adults over age 65 with stage II colon cancer and high-risk clinical features does not improve survival. Any possible survival benefit is likely less than 2% at 5 years, the study investigators say....

Reuters Health • The Doctor's Channel Daily Newscast

Chemotherapy sensitivity/resistance testing not ready for prime time

NEW YORK (Reuters Health) – No chemotherapy sensitivity and resistance assays have sufficient supporting evidence to justify their use in oncology practice. That’s the conclusion of an American Society of Clinical Oncology (ASCO) panel, reporting in the Journal of Clinical Oncology online July...

Reuters Health • The Doctor's Channel Daily Newscast

Occult lymph node metastasis does not impact breast cancer survival

NEW YORK (Reuters Health) – In women undergoing breast-conserving therapy for early breast cancer, the presence of occult metastasis not seen with routine pathological examination in sentinel lymph nodes (SLNs) is not associated with poorer survival. However, the presence of occult bone marrow metastasis...